The Effects of Taurolidine, a Novel Antineoplastic Agent, on Human Malignant Mesothelioma

November 15, 2004 |

Clinical Cancer Research Vol. 10, 7655-7661, November 15, 2004 [Link] Linda Nici, Barbara Monfils and Paul Calabresi Department of Medicine, Rhode Island Hospital and Brown University, Providence, Rhode Island Abstract Purpose: Malignant mesothelioma (MM) is a cancer with uniformly poor responses to current therapeutic regimens. This study evaluates whether taurolidine, a novel antineoplastic agent, is…

Read More